Literature DB >> 15485678

Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy.

Steffi Goffart1, Jürgen-Christoph von Kleist-Retzow, Rudolf J Wiesner.   

Abstract

During hypertrophy, proliferation of mitochondria does not keep pace with the increasing energy demand of the heart. This probably contributes importantly to cardiac failure, together with other phenotypic changes occurring during the growth process. The problem may be even aggravated if defects of mitochondrial function itself and not external factors cause the hypertrophic process. Here we review the basic mechanisms controlling mitochondrial biogenesis, especially the pathways coordinating expression of nuclear encoded mitochondrial genes and the small mitochondrial genome, and how these mechanisms may be connected to the cardiomyocyte differentiation program during development as well as under physiological and pathological circumstances.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485678     DOI: 10.1016/j.cardiores.2004.06.030

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  59 in total

1.  Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria.

Authors:  Dao-Fu Dai; Tony Chen; Jonathan Wanagat; Michael Laflamme; David J Marcinek; Mary J Emond; Calvin P Ngo; Tomas A Prolla; Peter S Rabinovitch
Journal:  Aging Cell       Date:  2010-04-29       Impact factor: 9.304

Review 2.  Autophagy in health and disease. 5. Mitophagy as a way of life.

Authors:  Roberta A Gottlieb; Raquel S Carreira
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-31       Impact factor: 4.249

3.  Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells.

Authors:  Susan Chung; Petras P Dzeja; Randolph S Faustino; Carmen Perez-Terzic; Atta Behfar; Andre Terzic
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-02

Review 4.  Heart Failure in Relation to Anthracyclines and Other Chemotherapies.

Authors:  Tolulope A Agunbiade; Raja Y Zaghlol; Ana Barac
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Oct-Dec

Review 5.  Cardiac nuclear receptors: architects of mitochondrial structure and function.

Authors:  Rick B Vega; Daniel P Kelly
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

6.  Quantitative proteomics reveals differential regulation of protein expression in recipient myocardium after trilineage cardiovascular cell transplantation.

Authors:  Ying-Hua Chang; Lei Ye; Wenxuan Cai; Yoonkyu Lee; Huseyin Guner; Youngsook Lee; Timothy J Kamp; Jianyi Zhang; Ying Ge
Journal:  Proteomics       Date:  2015-08       Impact factor: 3.984

Review 7.  Cardiac aging in mice and humans: the role of mitochondrial oxidative stress.

Authors:  Dao-Fu Dai; Peter S Rabinovitch
Journal:  Trends Cardiovasc Med       Date:  2009-10       Impact factor: 6.677

8.  Overexpression of Twinkle-helicase protects cardiomyocytes from genotoxic stress caused by reactive oxygen species.

Authors:  Jaakko L O Pohjoismäki; Siôn L Williams; Thomas Boettger; Steffi Goffart; Johnny Kim; Anu Suomalainen; Carlos T Moraes; Thomas Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.

Authors:  Asmaà Fritah; Jennifer H Steel; Donna Nichol; Nadeene Parker; Sharron Williams; Anthony Price; Leena Strauss; Timothy A Ryder; Margaret A Mobberley; Matti Poutanen; Malcolm Parker; Roger White
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

10.  Developmental and pathological changes in the human cardiac muscle mitochondrial DNA organization, replication and copy number.

Authors:  Jaakko L O Pohjoismäki; Steffi Goffart; Robert W Taylor; Douglas M Turnbull; Anu Suomalainen; Howard T Jacobs; Pekka J Karhunen
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.